Icu Medical [ICUI] vs AptarGroup [ATR] Detailed Stock Comparison
Icu Medical
NASDAQ
Loading...
AptarGroup
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Icu Medical wins in 6 metrics, AptarGroup wins in 13 metrics, with 0 ties. AptarGroup appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Icu Medical | AptarGroup | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -23.36 | 24.30 | Icu Medical |
| Price-to-Book Ratio | 1.61 | 3.43 | Icu Medical |
| Debt-to-Equity Ratio | 80.57 | 43.12 | AptarGroup |
| PEG Ratio | 19.02 | 23.73 | Icu Medical |
| EV/EBITDA | 13.45 | 12.70 | AptarGroup |
| Profit Margin (TTM) | -3.87% | 10.84% | AptarGroup |
| Operating Margin (TTM) | 4.89% | 15.17% | AptarGroup |
| EBITDA Margin (TTM) | 4.89% | 15.17% | AptarGroup |
| Return on Equity | -4.62% | 15.26% | AptarGroup |
| Return on Assets (TTM) | 1.79% | 7.10% | AptarGroup |
| Free Cash Flow (TTM) | $113.83M | $349.22M | AptarGroup |
| Dividend Yield | N/A | 0.90% | N/A |
| 1-Year Return | -26.10% | -2.22% | AptarGroup |
| Price-to-Sales Ratio (TTM) | 1.32 | 2.57 | Icu Medical |
| Enterprise Value | $4.50B | $10.15B | AptarGroup |
| EV/Revenue Ratio | 1.86 | 2.81 | Icu Medical |
| Gross Profit Margin (TTM) | 34.75% | 37.99% | AptarGroup |
| Revenue per Share (TTM) | $99 | $54 | Icu Medical |
| Earnings per Share (Diluted) | $-3.83 | $5.79 | AptarGroup |
| Beta (Stock Volatility) | 0.88 | 0.57 | AptarGroup |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Icu Medical vs AptarGroup Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Icu Medical | -13.13% | -11.42% | -14.86% | -21.01% | -29.37% | -28.57% |
| AptarGroup | 0.19% | -0.42% | -12.05% | -8.22% | -1.76% | -8.69% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Icu Medical | -26.10% | -34.08% | -39.53% | -7.36% | 227.20% | 279.07% |
| AptarGroup | -2.22% | 26.72% | 18.79% | 101.46% | 236.34% | 461.47% |
Performance & Financial Health Analysis: Icu Medical vs AptarGroup
| Metric | ICUI | ATR |
|---|---|---|
| Market Information | ||
| Market Cap | $3.20B | $9.27B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 236,310 | 520,779 |
| 90 Day Avg. Volume | 233,997 | 407,540 |
| Last Close | $112.85 | $140.76 |
| 52 Week Range | $109.00 - $196.26 | $130.85 - $178.03 |
| % from 52W High | -42.50% | -20.93% |
| All-Time High | $321.70 (Aug 06, 2018) | $178.03 (Nov 11, 2024) |
| % from All-Time High | -64.92% | -20.93% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | 0.06% |
| Quarterly Earnings Growth | 0.07% | 0.24% |
| Financial Health | ||
| Profit Margin (TTM) | -0.04% | 0.11% |
| Operating Margin (TTM) | 0.05% | 0.15% |
| Return on Equity (TTM) | -0.05% | 0.15% |
| Debt to Equity (MRQ) | 80.57 | 43.12 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $80.76 | $41.04 |
| Cash per Share (MRQ) | $12.11 | $2.58 |
| Operating Cash Flow (TTM) | $209.57M | $616.20M |
| Levered Free Cash Flow (TTM) | $77.29M | $291.79M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.90% |
| Last 12-Month Dividend | N/A | $1.35 |
Valuation & Enterprise Metrics Analysis: Icu Medical vs AptarGroup
| Metric | ICUI | ATR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -23.36 | 24.30 |
| Forward P/E | 19.02 | 23.73 |
| PEG Ratio | 19.02 | 23.73 |
| Price to Sales (TTM) | 1.32 | 2.57 |
| Price to Book (MRQ) | 1.61 | 3.43 |
| Market Capitalization | ||
| Market Capitalization | $3.20B | $9.27B |
| Enterprise Value | $4.50B | $10.15B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.86 | 2.81 |
| Enterprise to EBITDA | 13.45 | 12.70 |
| Risk & Other Metrics | ||
| Beta | 0.88 | 0.57 |
| Book Value per Share (MRQ) | $80.76 | $41.04 |
Financial Statements Comparison: Icu Medical vs AptarGroup
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ICUI | ATR |
|---|---|---|
| Revenue/Sales | $604.70M | $887.31M |
| Cost of Goods Sold | $394.59M | $550.89M |
| Gross Profit | $210.11M | $336.41M |
| Research & Development | $23.29M | N/A |
| Operating Income (EBIT) | $29.59M | $115.49M |
| EBITDA | $82.47M | $186.15M |
| Pre-Tax Income | $-10.91M | $106.02M |
| Income Tax | $4.57M | $27.35M |
| Net Income (Profit) | $-15.48M | $78.66M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ICUI | ATR |
|---|---|---|
| Cash & Equivalents | $289.70M | $125.84M |
| Total Current Assets | $1.42B | $1.51B |
| Total Current Liabilities | $549.02M | $1.21B |
| Long-Term Debt | $1.54B | $612.02M |
| Total Shareholders Equity | $1.99B | $2.55B |
| Retained Earnings | $674.68M | $2.42B |
| Property, Plant & Equipment | $466.20M | $66.57M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ICUI | ATR |
|---|---|---|
| Operating Cash Flow | $90.80M | $100.50M |
| Capital Expenditures | $-14.62M | $79,000 |
| Free Cash Flow | $34.47M | $23.41M |
| Debt Repayment | $-48.08M | $-4.55M |
| Common Stock Repurchase | N/A | $-80.00M |
Short Interest & Institutional Ownership Analysis
| Metric | ICUI | ATR |
|---|---|---|
| Shares Short | 1.18M | 901,388 |
| Short Ratio | 5.25 | 2.53 |
| Short % of Float | 0.06% | 0.02% |
| Average Daily Volume (10 Day) | 236,310 | 520,779 |
| Average Daily Volume (90 Day) | 233,997 | 407,540 |
| Shares Outstanding | 24.52M | 66.50M |
| Float Shares | 23.85M | 65.33M |
| % Held by Insiders | 0.03% | 0.01% |
| % Held by Institutions | 1.02% | 0.96% |
Dividend Analysis & Yield Comparison: Icu Medical vs AptarGroup
| Metric | ICUI | ATR |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.35 |
| Last 12-Month Dividend Yield | N/A | 0.90% |
| 3-Year Avg Annual Dividend | N/A | $1.50 |
| 3-Year Avg Dividend Yield | N/A | 0.32% |
| 3-Year Total Dividends | N/A | $4.51 |
| Ex-Dividend Date | N/A | Feb 05, 2025 |